Key result
Computational modeling demonstrates that increased oxygen carrying capacity (hematocrit) is the most salient factor for producing the respiratory collapse characteristic of silent hypoxemia in COVID-19.
Why the study?
Patients with COVID-19 can exhibit silent hypoxemia without breathing discomfort, but the mechanism underlying this blunted response to hypoxia remains unknown.
Does altering oxygen carrying capacity (hematocrit) in a computational respiratory model reproduce the silent hypoxemia phenotype seen in COVID-19?
Does altering oxygen carrying capacity (hematocrit) in a computational respiratory model reproduce the silent hypoxemia phenotype seen in COVID-19?
Computational modeling suggests that increased oxygen carrying capacity (hematocrit), rather than just altered chemosensitivity, is the most salient factor for producing the silent hypoxemia phenotype in COVID-19.
Model identifies elevated hematocrit as key driver of silent hypoxemia; hypothesis-generating and requires prospective validation before any clinical adoption.
Silent hypoxemia, or ‘happy hypoxia’, is a puzzling phenomenon in which patients who have contracted COVID-19 exhibit very low oxygen saturation (SaO 2 < 80%) but do not experience discomfort in breathing. The mechanism by which this blunted response to hypoxia occurs is unknown. We have previously shown that a computational model (Diekman et al., 2017, J. Neurophysiol) of the respiratory neural network can be used to test hypotheses focused on changes in chemosensory inputs to the central pattern generator (CPG). We hypothesize that altered chemosensory function at the level of the carotid bodies and/or the nucleus tractus solitarii are responsible for the blunted response to hypoxia. Here, we use our model to explore this hypothesis by altering the properties of the gain function representing oxygen sensing inputs to the CPG. We then vary other parameters in the model and show that oxygen carrying capacity is the most salient factor for producing silent hypoxemia. We call for clinicians to measure hematocrit as a clinical index of altered physiology in response to COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Diekman et al. (2023) studied COVID-19 silent hypoxemia. Altered oxygen carrying capacity and chemosensory function vs. Original normoxia model parameters was evaluated on Steady-state partial pressure of oxygen in arterial blood (PaO2) and respiratory collapse point. Computational modeling demonstrates that increased oxygen carrying capacity (hematocrit) is the most salient factor for producing the respiratory collapse characteristic of silent hypoxemia in COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: